This site is only for patients in the United Kingdom who have been prescribed CAMZYOS®▼ (mavacamten)

This site is only for patients in the United Kingdom who have been prescribed CAMZYOS®▼ (mavacamten)

Menu
FAQs
FAQs
FAQs
FAQs
FAQs
image

CAMZYOS resources

Resources

EMC, Electronic Medicines Compendium; HCM, hypertrophic cardiomyopathy.

3500-GB-2500166  |  October 2025

References

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. By reporting side effects, you can help provide more information on the safety of this medicine.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See yellowcard.mhra.gov.uk for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb on 0800 731 1736 or medical.information@bms.com

 

Legal Notice    |    Privacy Policy    |    Cookie Preferences

© 2025 MyoKardia, Inc., a Bristol-Myers Squibb company. All rights reserved.

3500-GB-2500234  |  October 2025